首页> 外文期刊>Expert review of ophthalmology >Usher syndrome: A review of the clinical phenotype, genes and therapeutic strategies
【24h】

Usher syndrome: A review of the clinical phenotype, genes and therapeutic strategies

机译:Usher综合征:临床表型,基因和治疗策略的审查。

获取原文
获取原文并翻译 | 示例
           

摘要

Usher syndrome (USH) is the most common cause of deaf-blindness in humans. It is a clinically and genetically heterogeneous disorder, for which 10 causative genes have been identified so far. The USH genes encode a number of structurally and functionally distinct proteins that form complexes in the inner ear and retina essential for hearing and vision. Animal studies have indicated that the hearing loss associated with USH mainly results from abnormal development of the hair bundle, the mechanoreceptive organelle of the sensory hair cells. In contrast, the molecular and cellular mechanisms underlying the USH visual impairment remain unclear. Although a cure for USH is not yet available, a host of promising therapeutic studies have made progress toward developing an effective treatment for the retinal defects associated with USH. This review provides an outline of the genes and proteins underlying USH, their interactions and functions in the inner ear and retina, and the therapeutic strategies that are under investigation as potential treatments for this disease.
机译:Usher综合征(USH)是人类失聪的最常见原因。这是一种临床和遗传异质性疾病,迄今为止已鉴定出10个致病基因。 USH基因编码许多在结构和功能上不同的蛋白质,这些蛋白质在内耳和视网膜中形成听觉和视觉必不可少的复合物。动物研究表明,与USH相关的听力损失主要是由发束,感觉性毛细胞的机械感受器细胞器的异常发育引起的。相比之下,USH视觉障碍的分子和细胞机制仍不清楚。尽管尚无法治愈USH,但许多有前途的治疗研究已在开发有效治疗与USH相关的视网膜缺陷的治疗方面取得了进展。这篇综述概述了USH的基因和蛋白质,它们在内耳和视网膜中的相互作用和功能,以及作为该病的潜在治疗方法正在研究的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号